These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 35577663

  • 81. Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon.
    LaForge K, Stack E, Shin S, Pope J, Larsen JE, Leichtling G, Leahy JM, Seaman A, Hoover D, Byers M, Barrie C, Chisholm L, Korthuis PT.
    J Subst Abuse Treat; 2022 Oct; 141():108849. PubMed ID: 35932759
    [Abstract] [Full Text] [Related]

  • 82.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 83. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S, Ferguson M, Palis H, Burmeister C, McDougall J, Liu L, Graham B, Ti L, Buxton JA.
    Int J Drug Policy; 2024 Jan; 123():104290. PubMed ID: 38101275
    [Abstract] [Full Text] [Related]

  • 84.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 85. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
    Wagner KD, Fiuty P, Page K, Tracy EC, Nocera M, Miller CW, Tarhuni LJ, Dasgupta N.
    Drug Alcohol Depend; 2023 Nov 01; 252():110985. PubMed ID: 37826988
    [Abstract] [Full Text] [Related]

  • 86. Harm reduction and emergency medical services: Opportunities for evidence-based programming.
    Friedman NMG, Molina CA, Glenn MJ.
    Am J Emerg Med; 2023 Oct 01; 72():85-87. PubMed ID: 37499554
    [Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88. Lay knowledge and practices of methamphetamine use to manage opioid-related overdose risks.
    Daniulaityte R, Silverstein SM, Getz K, Juhascik M, McElhinny M, Dudley S.
    Int J Drug Policy; 2022 Jan 01; 99():103463. PubMed ID: 34619443
    [Abstract] [Full Text] [Related]

  • 89. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G, Strike C.
    Harm Reduct J; 2020 May 07; 17(1):27. PubMed ID: 32381011
    [Abstract] [Full Text] [Related]

  • 90. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.
    Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R.
    Drug Alcohol Depend; 2020 Nov 01; 216():108202. PubMed ID: 32948372
    [Abstract] [Full Text] [Related]

  • 91. Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017-2019.
    Shrestha S, Stopka TJ, Hughto JMW, Case P, Palacios WR, Reilly B, Green TC.
    Harm Reduct J; 2021 Aug 30; 18(1):93. PubMed ID: 34461922
    [Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.
    Han Y, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L.
    Transl Psychiatry; 2019 Nov 11; 9(1):282. PubMed ID: 31712552
    [Abstract] [Full Text] [Related]

  • 94. Trends in Self-Reported Fentanyl and Other Illicit Substance Use in South Carolina Emergency Department Patients, 2020-2022.
    Lane SM, Jennings LK, Gainey SS, Barth KS, Haynes L, Moreland A, Hartwell K, Brady KT.
    J Emerg Med; 2023 Dec 11; 65(6):e534-e541. PubMed ID: 37872038
    [Abstract] [Full Text] [Related]

  • 95. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
    Ezell JM, Walters S, Friedman SR, Bolinski R, Jenkins WD, Schneider J, Link B, Pho MT.
    Soc Sci Med; 2021 Jan 11; 268():113470. PubMed ID: 33253992
    [Abstract] [Full Text] [Related]

  • 96. "They say it's fentanyl, but they honestly look like Perc 30s": Initiation and use of counterfeit fentanyl pills.
    Daniulaityte R, Sweeney K, Ki S, Doebbeling BN, Mendoza N.
    Harm Reduct J; 2022 May 25; 19(1):52. PubMed ID: 35614447
    [Abstract] [Full Text] [Related]

  • 97. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA, Buxton JA, Otterstatter M, Balshaw R, Gustafson R, Tyndall M, Kendall P, Kerr T, Gilbert M, Coombs D.
    Lancet Public Health; 2018 May 25; 3(5):e218-e225. PubMed ID: 29678561
    [Abstract] [Full Text] [Related]

  • 98. Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?
    McGowan CR, Harris M, Platt L, Hope V, Rhodes T.
    Int J Drug Policy; 2018 Aug 25; 58():31-36. PubMed ID: 29758542
    [Abstract] [Full Text] [Related]

  • 99. Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard.
    Waye KM, Yedinak JL, Koziol J, Marshall BDL.
    Int J Drug Policy; 2018 Dec 25; 62():86-93. PubMed ID: 30384027
    [Abstract] [Full Text] [Related]

  • 100. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J, Ciccarone D, Moran L, Outram S, Werb D, Thomas L, Arnold EA.
    Int J Environ Res Public Health; 2023 May 30; 20(11):. PubMed ID: 37297603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.